Going Viral Archives - Page 5 of 6

Going Viral

Earning CPD by listening to Healthed podcasts is simple. Each episode is eligible for Educational Activities CPD.

Filter results

Infectious diseases

Going Viral

0.5 EA, 0.5 RP

COVID Update – New advice, Coronary concern, Ba5

New advice on when to vaccinate after COVID infection

Expert/s: Prof Paul Griffin

Infectious diseases

Going Viral

0.5 EA, 0.5 RP

COVID update – Ba4 and Ba5, boosters, antivirals, long COVID

Should GPs have a fourth booster? The Ba4 and Ba5 variants, more information on the antivirals, long COVID is an emerging public health issue.

Expert/s: Prof Nancy Baxter

Infectious diseases

Going Viral

0.5 EA, 0.5 RP

COVID Update – Epidemiology, boosters, antivirals, future

A look at our local and national infection rates- what does the medium to long term future look like?

Expert/s: Prof Kristine Macartney

Infectious diseases

Going Viral

0.5 EA, 0.5 RP

COVID Update – Fourth jab, Ba2 update, flurona, antivirals

Ba2, Deltacron, Omicron and other variants- the winter booster - for which patients? An update on the other vaccines and the COVID antivirals.

Expert/s: Prof Paul Griffin

Infectious diseases

Going Viral

0.5 EA, 0.5 RP

COVID variants, antivirals, vaccines & vaccine hesitancy

Overseas travel and COVID - booster before travelling? What’s the evidence? The more transmissible OMICRON subvariant... is there any cause for concern here?

Expert/s: Prof Robert Booy

Neurology

Going Viral

0.5 EA, 0.5 RP

COVID and the Brain

Olfactory disturbances with COVID19 is evidence of brain involvement- consider a neuropsychological assessment for patients complaining of fatigue, poor attention span, slower processing speed.

Expert/s: A/Prof Lucette Cysique, Dr Clare Ramsden

Infectious diseases

Going Viral

0.5 EA, 0.5 RP

COVID Update – ATAGI, Fourth booster, Novavax, Post-COVID heart risk

A clinical overview of Novavax, is a fourth booster imminent for Australia? Post-COVID cardiovascular risk.

Expert/s: Prof Nigel Crawford

Infectious diseases, Respiratory and sleep

Going Viral

0.5 EA, 0.5 RP

COPD, COVID and other jabs

COVID is not the only preventable infectious disease - influenza, pertussis, and pneumonia are also very important

Expert/s: Prof Christine Jenkins

Infectious diseases, Travel medicine

Going Viral

0.5 EA, 0.5 RP

Why Africa may never be fully vaccinated – Stories from the frontline

Vaccine inequity is not the main reason the Congo is not immunised against COVID-19

Expert/s: Lindsay Thitchener

Infectious diseases

Going Viral

0.5 EA, 0.5 RP

Omicron – what’s new?

Boosters and other recent developments

Expert/s: Prof Nancy Baxter

Infectious diseases

Going Viral

0.5 EA, 0.5 RP

Is the current COVID response really protecting the economy?

Economic activity is down regardless because people voted with their feet and began to lockdown themselves

Expert/s: Prof Stephen Duckett

Infectious diseases

Going Viral

0.5 EA, 0.5 RP

COVID expert update – Boosters, RATS, schools, new variants and other FAQs

Listen to the booster update, introduction to the Novavax vaccine and the new Anti-viral therapies

Expert/s: Prof Kristine Macartney

COVID Update – New advice, Coronary concern, Ba5

New advice on when to vaccinate after COVID infection

Expert/s: Prof Paul Griffin

Going Viral

Infectious diseases

COVID update – Ba4 and Ba5, boosters, antivirals, long COVID

Should GPs have a fourth booster? The Ba4 and Ba5 variants, more information on the antivirals, long COVID is an emerging public health issue.

Expert/s: Prof Nancy Baxter

Going Viral

Infectious diseases

COVID Update – Epidemiology, boosters, antivirals, future

A look at our local and national infection rates- what does the medium to long term future look like?

Expert/s: Prof Kristine Macartney

Going Viral

Infectious diseases

COVID Update – Fourth jab, Ba2 update, flurona, antivirals

Ba2, Deltacron, Omicron and other variants- the winter booster - for which patients? An update on the other vaccines and the COVID antivirals.

Expert/s: Prof Paul Griffin

Going Viral

Infectious diseases

COVID variants, antivirals, vaccines & vaccine hesitancy

Overseas travel and COVID - booster before travelling? What’s the evidence? The more transmissible OMICRON subvariant... is there any cause for concern here?

Expert/s: Prof Robert Booy

Going Viral

Infectious diseases

COVID and the Brain

Olfactory disturbances with COVID19 is evidence of brain involvement- consider a neuropsychological assessment for patients complaining of fatigue, poor attention span, slower processing speed.

Expert/s: A/Prof Lucette Cysique, Dr Clare Ramsden

Going Viral

Neurology

COVID Update – ATAGI, Fourth booster, Novavax, Post-COVID heart risk

A clinical overview of Novavax, is a fourth booster imminent for Australia? Post-COVID cardiovascular risk.

Expert/s: Prof Nigel Crawford

Going Viral

Infectious diseases

COPD, COVID and other jabs

COVID is not the only preventable infectious disease - influenza, pertussis, and pneumonia are also very important

Expert/s: Prof Christine Jenkins

Going Viral

Infectious diseases, Respiratory and sleep

Why Africa may never be fully vaccinated – Stories from the frontline

Vaccine inequity is not the main reason the Congo is not immunised against COVID-19

Expert/s: Lindsay Thitchener

Going Viral

Infectious diseases, Travel medicine

Omicron – what’s new?

Boosters and other recent developments

Expert/s: Prof Nancy Baxter

Going Viral

Infectious diseases

Is the current COVID response really protecting the economy?

Economic activity is down regardless because people voted with their feet and began to lockdown themselves

Expert/s: Prof Stephen Duckett

Going Viral

Infectious diseases

COVID expert update – Boosters, RATS, schools, new variants and other FAQs

Listen to the booster update, introduction to the Novavax vaccine and the new Anti-viral therapies

Expert/s: Prof Kristine Macartney

Going Viral

Infectious diseases

Going Viral

Filter results

New advice on when to vaccinate after COVID infection

Should GPs have a fourth booster? The Ba4 and Ba5 variants, more information on the antivirals, long COVID is an emerging public health issue.

A look at our local and national infection rates- what does the medium to long term future look like?

Ba2, Deltacron, Omicron and other variants- the winter booster - for which patients? An update on the other vaccines and the COVID antivirals.

Overseas travel and COVID - booster before travelling? What’s the evidence? The more transmissible OMICRON subvariant... is there any cause for concern here?

Olfactory disturbances with COVID19 is evidence of brain involvement- consider a neuropsychological assessment for patients complaining of fatigue, poor attention span, slower processing speed.

A clinical overview of Novavax, is a fourth booster imminent for Australia? Post-COVID cardiovascular risk.

COVID is not the only preventable infectious disease - influenza, pertussis, and pneumonia are also very important

Vaccine inequity is not the main reason the Congo is not immunised against COVID-19

Boosters and other recent developments

Economic activity is down regardless because people voted with their feet and began to lockdown themselves

Listen to the booster update, introduction to the Novavax vaccine and the new Anti-viral therapies

New advice on when to vaccinate after COVID infection

Should GPs have a fourth booster? The Ba4 and Ba5 variants, more information on the antivirals, long COVID is an emerging public health issue.

A look at our local and national infection rates- what does the medium to long term future look like?

Ba2, Deltacron, Omicron and other variants- the winter booster - for which patients? An update on the other vaccines and the COVID antivirals.

Overseas travel and COVID - booster before travelling? What’s the evidence? The more transmissible OMICRON subvariant... is there any cause for concern here?

Olfactory disturbances with COVID19 is evidence of brain involvement- consider a neuropsychological assessment for patients complaining of fatigue, poor attention span, slower processing speed.

A clinical overview of Novavax, is a fourth booster imminent for Australia? Post-COVID cardiovascular risk.

COVID is not the only preventable infectious disease - influenza, pertussis, and pneumonia are also very important

Vaccine inequity is not the main reason the Congo is not immunised against COVID-19

Boosters and other recent developments

Economic activity is down regardless because people voted with their feet and began to lockdown themselves

Listen to the booster update, introduction to the Novavax vaccine and the new Anti-viral therapies

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

Abnormal Liver Function Test Interpretation

Tuesday 31st March, 7pm - 9pm AEDT

Speaker

Dr Emily Nash

Gastroenterologist and Hepatologist; Chris O'Brien Lifehouse; Clinical Associate Lecturer, University of Sydney

Join Dr Emily Nash for their lecture where they will offer a framework to interpret abnormal LFTS and suggest diagnostic algorithms to help determine the most appropriate next step.